| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &General Counsel
1 company
Prevoznik Michael E is a SVP &General Counsel at QUEST DIAGNOSTICS INC. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $7.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2021 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 1,188 | $116.95 | $138,936.60 | -1.4% | |
| Oct 14, 2020 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sale+OE | 35,591 | $119.00 | $4,235,329.00 | -47.0% | |
| Mar 11, 2020 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 2,175 | $104.25 | $226,743.75 | -5.1% | |
| Feb 27, 2020 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 1,011 | $109.68 | $110,883.69 | -1.2% | |
| Nov 27, 2019 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sale+OE | 44,556 | $107.43 | $4,786,564.05 | -22.7% | |
| Mar 4, 2019 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 3,373 | $86.81 | $292,810.13 | -7.9% | |
| Feb 27, 2019 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 1,412 | $86.65 | $122,352.32 | -1.7% | |
| Feb 25, 2019 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 336 | $88.23 | $29,645.28 | -0.8% | |
| Jul 10, 2018 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sale+OE | 30,780 | $113.07 | $3,480,140.70 | -43.6% | |
| Mar 5, 2018 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 4,128 | $101.00 | $416,928.00 | -9.4% |